Clinical Trial Update: S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating acetyl-L-carnitine to prevent chemotherapy-induced peripheral neuropathy in women with stage I-IIIa breast cancer undergoing chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer, Chemotherapeutic Agent Toxicity | Phase 3 | Status: COMPLETED | Results posted: 2017-04-10